Hirofumi Ochi
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis.
Journal: Journal of neurology
Published: March 22, 2026
Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 24, 2026
Symptoms and Signs of Multiple Sclerosis: Beyond Charcot's Triad
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: November 13, 2025
B cell depletion as a therapeutic strategy for neuromyelitis optica spectrum disorder: rationale, evidence, and challenges.
Journal: Frontiers in immunology
Published: May 27, 2025
Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey.
Journal: Neurology
Published: October 30, 2024
CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica.
Journal: Brain : a journal of neurology
Published: May 21, 2024
A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.
Journal: Multiple sclerosis and related disorders
Published: March 19, 2024
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan.
Journal: Multiple sclerosis and related disorders
Published: February 03, 2024
Case report: Frontotemporal dementia and amyotrophic lateral sclerosis caused by a missense variant (p.Arg89Trp) in the valosin-containing protein gene.
Journal: Frontiers in genetics
Published: February 01, 2023
Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis.
Journal: Frontiers in neurology
Published: August 06, 2022
Disability Progression in SPMS Despite Therapeutic Intervention: Refractory SPMS
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: May 19, 2022
Dermal advanced glycation end-product accumulation is associated with sarcopenia-related measures in middle-aged and older men.
Journal: Archives of gerontology and geriatrics
Published: February 13, 2022
Last Updated: 09/26/2026